MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo

被引:219
作者
Fontan, Lorena [2 ,3 ,5 ]
Yang, Chenghua [1 ]
Kabaleeswaran, Venkataraman [1 ,6 ,7 ]
Volpon, Laurent [8 ]
Osborne, Michael J. [8 ]
Beltran, Elena [5 ]
Garcia, Monica [2 ,3 ]
Cerchietti, Leandro [2 ]
Shaknovich, Rita [2 ,4 ]
Yang, Shao Ning [2 ]
Fang, Fang [2 ,3 ]
Gascoyne, Randy D. [9 ]
Angel Martinez-Climent, Jose [5 ]
Glickman, J. Fraser [10 ]
Borden, Katherine [8 ]
Wu, Hao [1 ,6 ,7 ]
Melnick, Ari [2 ,3 ]
机构
[1] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA
[2] Weill Cornell Med Coll, Div Hematol & Med Oncol, New York, NY 10021 USA
[3] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10021 USA
[4] Weill Cornell Med Coll, Dept Pathol, Div Immunopathol, New York, NY 10021 USA
[5] Univ Navarra, Ctr Appl Med Res, Div Oncol, Navarra 31008, Spain
[6] Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[8] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada
[9] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC V5Z 1L3, Canada
[10] Rockefeller Univ, High Throughput Screening Resource Ctr, New York, NY 10065 USA
关键词
B-CELL LYMPHOMA; NF-KAPPA-B; KINASE-C INHIBITOR; T-CELL; CHROMOSOMAL TRANSLOCATION; PARACASPASE MALT1; CRYSTAL-STRUCTURE; PROTEASE ACTIVITY; HODGKIN-LYMPHOMA; TISSUE LYMPHOMA;
D O I
10.1016/j.ccr.2012.11.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MALT1 cleavage activity is linked to the pathogenesis of activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL), a chemoresistant form of DLBCL. We developed a MALT1 activity assay and identified chemically diverse MALT1 inhibitors. A selected lead compound, MI-2, featured direct binding to MALT1 and suppression of its protease function. MI-2 concentrated within human ABC-DLBCL cells and irreversibly inhibited cleavage of MALT1 substrates. This was accompanied by NE-kappa B reporter activity suppression, c-REL nuclear localization inhibition, and NF-kappa B target gene downregulation. Most notably, MI-2 was nontoxic to mice, and displayed selective activity against ABC-DLBCL cell lines in vitro and xenotransplanted ABC-DLBCL tumors in vivo. The compound was also effective against primary human non-germinal center B cell-like DLBCLs ex vivo.
引用
收藏
页码:812 / 824
页数:13
相关论文
共 47 条
[11]   Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-κB and MAPK activation to selectively control cytokine production [J].
Gross, Olaf ;
Grupp, Christina ;
Steinberg, Christian ;
Zimmermann, Stephanie ;
Strasser, Dominikus ;
Hannesschlaeger, Nicole ;
Reindl, Wolfgang ;
Jonsson, Helena ;
Huo, Hairong ;
Littman, Dan R. ;
Peschel, Christian ;
Yokoyama, Wayne M. ;
Krug, Anne ;
Ruland, Juergen .
BLOOD, 2008, 112 (06) :2421-2428
[12]   Mechanism and specificity of the human paracaspase MALT1 [J].
Hachmann, Janna ;
Snipas, Scott J. ;
van Raam, Bram J. ;
Cancino, Erik M. ;
Houlihan, Emily J. ;
Poreba, Marcin ;
Kasperkiewicz, Paulina ;
Drag, Marcin ;
Salvesen, Guy S. .
BIOCHEMICAL JOURNAL, 2012, 443 :287-295
[13]   Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines [J].
Hailfinger, Stephan ;
Nogai, Hendrik ;
Pelzer, Christiane ;
Jaworski, Maike ;
Cabalzar, Katrin ;
Charton, Jean-Enno ;
Guzzardi, Montserrat ;
Decaillet, Chantal ;
Grau, Michael ;
Doerken, Bernd ;
Lenz, Peter ;
Lenz, Georg ;
Thome, Margot .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (35) :14596-14601
[14]   Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma [J].
Hailfinger, Stephan ;
Lenz, Georg ;
Ngo, Vu ;
Posvitz-Fejfar, Anita ;
Rebeaud, Fabien ;
Guzzardi, Montserrat ;
Penas, Eva-Maria Murga ;
Dierlamm, Judith ;
Chan, Wing C. ;
Staudt, Louis M. ;
Thome, Margot .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (47) :19946-19951
[15]   Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J].
Hans, CP ;
Weisenburger, DD ;
Greiner, TC ;
Gascoyne, RD ;
Delabie, J ;
Ott, G ;
Müller-Hermelink, HK ;
Campo, E ;
Braziel, RM ;
Jaffe, ES ;
Pan, ZG ;
Farinha, P ;
Smith, LM ;
Falini, B ;
Banham, AH ;
Rosenwald, A ;
Staudt, LM ;
Connors, JM ;
Armitage, JO ;
Chan, WC .
BLOOD, 2004, 103 (01) :275-282
[16]   The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy [J].
Honigberg, Lee A. ;
Smith, Ashley M. ;
Sirisawad, Mint ;
Verner, Erik ;
Loury, David ;
Chang, Betty ;
Li, Shyr ;
Pan, Zhengying ;
Thamm, Douglas H. ;
Miller, Richard A. ;
Buggy, Joseph J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (29) :13075-13080
[17]   TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas [J].
Honma, Keiichiro ;
Tsuzuki, Shinobu ;
Nakagawa, Masao ;
Tagawa, Hiroyuki ;
Nakamura, Shigeo ;
Morishima, Yasuo ;
Seto, Masao .
BLOOD, 2009, 114 (12) :2467-2475
[18]   Oncogenic CARD11 mutations in human diffuse large B cell lymphoma [J].
Lenz, Georg ;
Davis, R. Eric ;
Ngo, Vu N. ;
Lam, Lloyd ;
George, Thaddeus C. ;
Wright, George W. ;
Dave, Sandeep S. ;
Zhao, Hong ;
Xu, Weihong ;
Rosenwald, Andreas ;
Ott, German ;
Muller-Hermelink, Hans Konrad ;
Gascoyne, Randy D. ;
Connors, Joseph M. ;
Rimsza, Lisa M. ;
Campo, Elias ;
Jaffe, Elaine S. ;
Delabie, Jan ;
Smeland, Erlend B. ;
Fisher, Richard I. ;
Chan, Wing C. ;
Staudt, Louis M. .
SCIENCE, 2008, 319 (5870) :1676-1679
[19]   Mechanisms of Disease: Aggressive Lymphomas. [J].
Lenz, Georg ;
Staudt, Louis M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15) :1417-1429
[20]   Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies [J].
Lim, Kian-Huat ;
Yang, Yibin ;
Staudt, Louis M. .
IMMUNOLOGICAL REVIEWS, 2012, 246 :359-378